Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent
Alex A. Adjei
Medical Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
150
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Pemetrexed
100%
Antineoplastic Agents
72%
Folic Acid
25%
glycinamide ribonucleotide
23%
Non-Small Cell Lung Carcinoma
22%
thymidylate synthase-dihydrofolate reductase
21%
Hydroxymethyl and Formyl Transferases
21%
Platinum Compounds
18%
Antimetabolites
16%
Vinorelbine
16%
Mesothelioma
15%
Oxaliplatin
14%
Carboplatin
14%
gemcitabine
14%
Vitamin B 12
13%
Enzymes
13%
Dietary Supplements
12%
Urinary Bladder Neoplasms
12%
Pancreatic Neoplasms
11%
Uterine Cervical Neoplasms
11%
Cisplatin
11%
Stomach Neoplasms
10%
Colorectal Neoplasms
10%
Bone Marrow
9%
Breast Neoplasms
8%
Neoplasms
4%